- Home
- DTIL
as 05-30-2025 4:00pm EST
Precision BioSciences Inc is a genome editing company dedicated to improving life through its genome editing platform, ARCUS. It leverages ARCUS in the development of its product candidates, which are designed to treat human diseases and provide food and agricultural solutions. The ARCUS is in its relatively small size which potentially allows delivery to a wider range of cells and tissues using viral and non-viral gene delivery methods.
| Founded: | 2006 | Country: | United States |
| Employees: | N/A | City: | DURHAM |
| Market Cap: | 51.6M | IPO Year: | 2019 |
| Target Price: | $47.00 | AVG Volume (30 days): | 74.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 2 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.79 | EPS Growth: | N/A |
| 52 Week Low/High: | $3.61 - $13.32 | Next Earning Date: | 05-15-2025 |
| Revenue: | $51,141,000 | Revenue Growth: | -11.11% |
| Revenue Growth (this year): | -67.38% | Revenue Growth (next year): | 30.20% |
Stock Insider Trading Activity of Precision BioSciences Inc. (DTIL)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Buehler Kevin | DTIL | Director | Mar 26 '25 | Buy | $4.67 | 4,523 | $21,122.41 | 13,235 | |
| Brown Melinda | DTIL | Director | Mar 26 '25 | Buy | $4.75 | 1,839 | $8,735.25 | 9,057 | |
| Germano Geno J | DTIL | Director | Mar 25 '25 | Buy | $5.30 | 3,250 | $17,225.00 | 11,057 | |
| Amoroso Michael | DTIL | President and CEO | Mar 21 '25 | Sell | $5.56 | 964 | $5,359.84 | 109,540 | |
| Scimeca Dario | DTIL | General Counsel and Secretary | Mar 3 '25 | Sell | $4.91 | 272 | $1,335.52 | 25,000 | |
| SMITH J. JEFFERSON | DTIL | Chief Research Officer | Mar 3 '25 | Sell | $4.91 | 154 | $756.14 | 87,805 |
Latest Precision BioSciences Inc. News
DTIL Breaking Stock News: Dive into DTIL Ticker-Specific Updates for Smart Investing
GOBankingRates
14 hours ago
7 Luxury Vehicles Expected To Skyrocket in Price Due To Trump’s Tariffs
GOBankingRates
14 hours ago
3 International Vacations That Are Cheaper Than an iPhone
GOBankingRates
14 hours ago
Suze Orman’s 5 Best Tips for Saving Money Even When Living Paycheck to Paycheck
Yahoo Finance
14 hours ago
This week in Trumponomics: Too bad TACO isn’t true
The Guardian
14 hours ago
Starmer says Farage would spook the City and give us Truss 2 – he could be right
Yahoo Finance Video
14 hours ago
AI ecosystem isn't just Nvidia: Unlock it further with this ETF
Benzinga
14 hours ago
Is Dave Ramsey's Home Buying Advice Realistic For The Average Homeowner?
Reuters
14 hours ago
Ford recalls more than 29,000 vehicles in the US, NHTSA says
Compare DTIL vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "DTIL Precision BioSciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.